Explore Our Comprehensive Pharmaceuticals Industry Research Reports
P
2023
The global generic drugs market was valued at $385.3 billion in 2022, and is projected to reach $835.7 billion by 2032, growing at a CAGR of 8.1% from 2023 to 2032.
Report Code : A03793 | Pages : 252 | Category : Life Sciences
U
2024
A generic injectable is a drug that has the same active pharmaceutical ingredient as its branded counterpart. A generic injectable is also equivalent to its branded counterpart in ...
Report Code : A11552 | Category : Life Sciences
U
2022
Generic drugs are pharmaceutical drugs with similar chemical makeup of a branded drug. Generic drugs are cheaper in Japan and equivalent to branded drugs in dosage, strength, route ...
Report Code : A03804 | Category : Life Sciences
U
2024
A branded generic is a generic drug that has gone through the ANDA process, and is assigned a name other than its chemical name. These branded generic drugs ...
Report Code : A10537 | Category : Life Sciences
P
2023
By component, the Oral was the dominant sub-segment with major market share in 2022 in the North America Generic Drugs Market. This sub-segment is likely to follow same momentum by the end of 2032.
Report Code : A156833 | Pages : 114 | Category : Life Sciences
P
2023
The Route Of Administration dominated the market with highest revenue share over the analysis period. The section Top Investment Pockets from report provides insights about most lucrative segment for investment in the market.
Report Code : A156835 | Pages : 73 | Category : Life Sciences
P
2023
By end user, the Mexico Generic Drugs Market market is bifurcated into various sectors, Of those, Route Of Administration was the largest segment and captured considerable market share in 2022.
Report Code : A156836 | Pages : 85 | Category : Life Sciences
P
2023
North America region a dominant position in 2032. The market size section covers country-level market size and forecast which also includes the COVID-19 impact.
Report Code : A156837 | Pages : 119 | Category : Life Sciences
P
2023
By end user, the Spain Generic Drugs Market market is bifurcated into various sectors, Of those, Route Of Administration was the largest segment and captured considerable market share in 2022.
Report Code : A156838 | Pages : 90 | Category : Life Sciences
P
2023
The Germany Generic Drugs Market segment Route Of Administration is expected to witness highest CAGR during the forecast period. The report provides insights about opportunities that would help the market to expand in future.
Report Code : A156839 | Pages : 85 | Category : Life Sciences
Register and Earn 500 Loyalty Points
An Email Verification Code has been sent to your email address!
Please check your inbox and, if you don't find it there, also look in your junk folder.